Abstract
Objective
Autosomal dominant polycystic kidney disease (ADPKD) is mainly caused by the pathogenic mutation of PKD1 or PKD2 gene and usually affects bilateral kidneys. Synonymous mutations are generally assumed to be neutral as they do not alter amino acids. Herein, we described an extremely rare ADPKD child caused by a heterozygous synonymous mutation of PKD2 gene accompanied by massive proteinuria and congenital solitary kidney.
Methods
Clinical characteristics of the patients were summarized. Whole-exome sequencing was performed to screen the disease-causing gene mutation, and reverse transcription polymerase chain reaction (RT-PCR) and Sanger sequencing were applied to analyze the impact of the identified mutation on gene transcription and splicing.
Results
Polycystic changes were found in the solitary kidney of a girl initially presented with nephrotic-range proteinuria. Thereafter her mother and 2 other family members were diagnosed to be ADPKD. Whole-exome sequencing of the proband identified a heterozygous synonymous mutation (c.1716G>A, p.Lys572=) located in the splicing site of exon 7 in PKD2 gene, which was co-segregated with the PKD phenotype in the family. RT-PCR and direct sequencing of amplified products revealed that this heterozygous synonymous mutation led to exon7 skipping in PKD2 gene.
Conclusion
We reported an extremely rare child case of ADPKD2 in combination with solitary kidney and nephrotic-range proteinuria, and firstly confirmed the pathogenicity of a heterozygous synonymous mutation (c.1716G>A) in PKD2 gene. The results indicate that synonymous mutations should not be excluded from disease-causing if they are located in splicing site of an exon.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Barua M, Pei Y. Diagnosis of Autosomal-Dominant Polycystic Kidney Disease: An Integrated Approach. Semin Nephrol, 2010,30(4):356–365
Rossetti S, Consugar MB, Chapman AB, et al. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol, 2007,18(7):2143–2160
Cornec-Le Gall E, Audrezet MP, Chen JM, et al. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol, 2013,24(6):1006–1013
Vester U, Kranz B, Hoyer PF. The diagnostic value of ultrasound in cystic kidney diseases. Pediatr Nephrol, 2010,25(2):231–240
Chapman AB, Johnson AM, Gabow PA, et al. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol, 1994,5(6):1349–1354
Hoffmeister H, Gallagher AR, Rascle A, et al. The human polycystin-2 protein represents an integral membrane protein with six membrane-spanning domains and intracellular N- and C-termini. Biochem J, 2011,433(2):285–294
Nauli SM, Alenghat FJ, Luo Y, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet, 2003,33(2):129–137
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015, 17(5):405–424
Gonzalez-Paredes FJ, Ramos-Trujillo E, Claverie-Martin F. Three exonic mutations in polycystic kidney disease-2 gene (PKD2) alter splicing of its pre-mRNA in a minigene system. Gene, 2016,578(1):117–123
Waterhouse A, Bertoni M, Bienert S, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res, 2018,46(W1):W296–W303
Sauna ZE, Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet, 2011,12(10):683–691
Buratti E, Baralle M, Baralle FE. Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res, 2006,34(12):3494–3510
Anna A, Monika G. Splicing mutations in human genetic disorders: examples, detection, and confirmation. J Appl Genet, 2018,59(3):253–268
Hackmann K, Markoff A, Qian F, et al. A splice form of polycystin-2, lacking exon 7, does not interact with polycystin-1. Hum Mol Genet, 2005,14(21):3249–3262
Baralle FE, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol, 2017,18(7):437–451
Rossetti S, Kubly VJ, Consugar MB, et al. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int, 2009,75(8):848–855
Tan YC, Blumenfeld J, Michaeel A, et al. Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease. Clin Genet, 2011,80(3):287–292
Grieben M, Pike AC, Shintre CA, et al. Structure of the polycystic kidney disease TRP channel Polycystin-2 (PC2). Nat Struct Mol Biol, 2017,24(2):114–122
Wiesel A, Queisser-Luft A, Clementi M, et al. Prenatal detection of congenital renal malformations by fetal ultrasonographic examination: an analysis of 709,030 births in 12 European countries. Eur J Med Genet, 2005,48(2):131–144
Nicolaou N, Renkema KY, Bongers EM, et al. Genetic, environmental, and epigenetic factors involved in CAKUT. Nat Rev Nephrol, 2015,11(12):720–731
Poster D, Kistler AD, Krauer F, et al. Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series. Am J Kidney Dis, 2009,54(3):450–458
Peces R, Vega C, Aguilar A, et al. Autosomal dominant polycystic kidney disease with contralateral renal agenesis. Nefrologia, 2012,32(6):839–842
Jeong GH, Park BS, Jeong TK, et al. Unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis: a case report. J Korean Med Sci, 2003,18(2):284–286
Bear RA. Solitary Kidney Affected with Polycystic Disease: A Report of 2 Cases. J Urology, 1974,111(5): 566–567
Sirvent AE, Enriquez R, Ardoy F, et al. Autosomal dominant polycystic kidney disease with congenital absence of contralateral kidney. Int Urol Nephrol, 2006, 38(3–4):773–774
Todorov VV. The diagnostic dilemma of the unilateral cystic kidney-ADPKD with aplasia of one kidney. Nephrol Dial Transplant, 1999,14(11):2775
Krzemien G, Turczyn A, Panczyk-Tomaszewska M, et al. Long-term follow up of a boy with unilateral autosomal dominant polycystic kidney disease and contralateral renal agenesis. Dev Period Med, 2017,21(4):380–383
Visciano B, Di Pietro RA, Rossano R, et al. Nephrotic syndrome and autosomal dominant polycystic kidney disease. Clin Kidney J, 2012,5(6):508–511
Siomou E, Jarvis J, Hulton SA. Autosomal dominant polycystic kidney disease (ADPKD) associated with steroid-sensitive nephrotic syndrome in childhood. Pediatr Nephrol, 2011,26(4):643–644
Kiprov DD, Colvin RB, McCluskey RT. Focal and segmental glomerulosclerosis and porteinuria associated with unilateral renal agenesis. Lab Invest, 1982,46(3):275–281
Thorner PS, Arbus GS, Celermajer DS, et al. Focal segmental glomerulosclerosis and progressive renal failure associated with a unilateral kidney. Pediatrics, 1984,73(6):806–810
Gutierrez-Millet V, Nieto J, Praga M, et al. Focal glomerulosclerosis and proteinuria in patients with solitary kidneys. Arch Intern Med, 1986,146(4):705–709
Oshiro Y, Umena S, Noda M. Focal segmental glomerulosclerosis complicating solitary kidney. Clin Exp Nephrol, 2009,13(1):81–84
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by the National Natural Science Foundation of China (No. 81873596).
Conflict of Interest Statement
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Deng, Lx., Yang, Y., Yang, J. et al. A Presumed Synonymous Mutation of PKD2 Caused Autosomal Dominant Polycystic Kidney Disease in a Chinese Family. CURR MED SCI 41, 1029–1036 (2021). https://doi.org/10.1007/s11596-021-2436-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-021-2436-9